Stockscreener 앱 받기
20.84
2.12%
-0.715
Dianthus Therapeutics Inc 주식(DNTH)의 최신 뉴스
Dianthus Therapeutics, Inc. (NASDAQ:DNTH) Shares Sold by Avidity Partners Management LP - MarketBeat
Barclays PLC Raises Stake in Dianthus Therapeutics, Inc. (NASDAQ:DNTH) - Defense World
180,000 Shares in Dianthus Therapeutics, Inc. (NASDAQ:DNTH) Acquired by Adage Capital Partners GP L.L.C. - MarketBeat
Dianthus Therapeutics completes enrollment for MaGic trial - Investing.com
Dianthus Therapeutics completes enrollment for MaGic trial By Investing.com - Investing.com India
Breakthrough gMG Treatment DNTH103 Hits Major Milestone: Phase 2 Results Coming This Fall - Stock Titan
Invesco Ltd. Purchases 790 Shares of Dianthus Therapeutics, Inc. (NASDAQ:DNTH) - Defense World
TCG Crossover Management LLC Takes Position in Dianthus Therapeutics, Inc. (NASDAQ:DNTH) - MarketBeat
25,000 Shares in Dianthus Therapeutics, Inc. (NASDAQ:DNTH) Purchased by Allostery Investments LP - MarketBeat
Ally Bridge Group NY LLC Makes New Investment in Dianthus Therapeutics, Inc. (NASDAQ:DNTH) - MarketBeat
Dianthus Therapeutics, Inc. (NASDAQ:DNTH) Shares Sold by 5AM Venture Management LLC - MarketBeat
JPMorgan Chase & Co. Increases Stake in Dianthus Therapeutics, Inc. (NASDAQ:DNTH) - Defense World
Dianthus Therapeutics (DNTH) to Release Quarterly Earnings on Thursday - MarketBeat
Dianthus Therapeutics (NASDAQ:DNTH) Shares Gap DownHere's What Happened - MarketBeat
Analysts Set Dianthus Therapeutics, Inc. (NASDAQ:DNTH) PT at $54.33 - MarketBeat
Legal & General Group Plc Buys 2,363 Shares of Dianthus Therapeutics, Inc. (NASDAQ:DNTH) - Defense World
Dianthus Therapeutics, Inc. (NASDAQ:DNTH) Given Consensus Recommendation of “Buy” by Brokerages - Defense World
BlackRock, Inc. Reduces Stake in Dianthus Therapeutics Inc. - GuruFocus
Dianthus Therapeutics to Participate in Two Upcoming Investor Events - The Manila Times
Dianthus Therapeutics Reveals Growth Strategy at Two Elite Healthcare Investment Forums - Stock Titan
Dianthus Therapeutics (DNTH) Sees Rise in Short Interest Despite Stock Rebound | DNTH Stock News - GuruFocus
Dianthus Therapeutics (NASDAQ:DNTH) Shares Up 7.4%Time to Buy? - MarketBeat
Bain Capital Life Sciences Investors LLC Sells 323,716 Shares of Dianthus Therapeutics, Inc. (NASDAQ:DNTH) - MarketBeat
Walleye Capital LLC Purchases 52,890 Shares of Dianthus Therapeutics, Inc. (NASDAQ:DNTH) - MarketBeat
Dianthus Therapeutics: Complement Therapy Developer With Long Road Ahead - Seeking Alpha
Dianthus Therapeutics, Inc. (NASDAQ:DNTH) Shares Bought by Geode Capital Management LLC - Defense World
Fmr LLC Purchases 36,133 Shares of Dianthus Therapeutics, Inc. (NASDAQ:DNTH) - MarketBeat
Vanguard Group Inc. Sells 20,331 Shares of Dianthus Therapeutics, Inc. (NASDAQ:DNTH) - MarketBeat
A stock that deserves closer examination: Dianthus Therapeutics Inc (DNTH) - uspostnews.com
Wellington Management Group LLP Boosts Stock Position in Dianthus Therapeutics, Inc. (NASDAQ:DNTH) - Defense World
KLP Kapitalforvaltning AS Acquires New Position in Dianthus Therapeutics, Inc. (NASDAQ:DNTH) - Defense World
Dianthus Therapeutics, Inc. (NASDAQ:DNTH) Shares Sold by Corebridge Financial Inc. - Defense World
Dianthus Therapeutics, Inc. (NASDAQ:DNTH) Shares Acquired by Alliancebernstein L.P. - MarketBeat
ADAR1 Capital Management LLC Sells 101,055 Shares of Dianthus Therapeutics, Inc. (NASDAQ:DNTH) - MarketBeat
Dianthus Therapeutics, Inc. (NASDAQ:DNTH) Shares Purchased by American Century Companies Inc. - Defense World
Brokerages Set Dianthus Therapeutics, Inc. (NASDAQ:DNTH) Target Price at $54.33 - MarketBeat
Rhenman & Partners Asset Management AB Sells 36,000 Shares of Dianthus Therapeutics, Inc. (NASDAQ:DNTH) - MarketBeat
Dianthus Therapeutics, Inc. (DNTH) Soars 6.1%: Is Further Upside Left in the Stock? - MSN
2.71%
자본화:
|
볼륨(24시간):